Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.1800
0.00 (0.00%)
Jun 8, 2026, 9:30 AM EST
Integrated BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -1.65 | 0.81 | 0.11 | -0.03 | 3.84 | 8.01 |
Depreciation & Amortization | 1.34 | 1.27 | 1.22 | 1.15 | 0.83 | 0.83 |
Loss (Gain) From Sale of Assets | 0 | 0 | 0 | -0 | -0.02 | -0.01 |
Asset Writedown & Restructuring Costs | - | 0.03 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.06 | -0 |
Stock-Based Compensation | 0.19 | 0.19 | 0.25 | 0.32 | 0.37 | 0.23 |
Provision & Write-off of Bad Debts | 0.02 | 0.02 | -0.04 | 0 | - | 0.03 |
Other Operating Activities | 0.54 | 1.25 | 0.14 | 0.08 | -1.5 | -2.98 |
Change in Accounts Receivable | 1.41 | -0.78 | -0.12 | 0.37 | 0.88 | -0.29 |
Change in Inventory | 1.96 | 1.88 | -0.98 | 0.79 | 0.64 | -1.59 |
Change in Accounts Payable | 0.46 | -0.21 | 0.24 | -0.92 | -0.22 | -0.94 |
Change in Other Net Operating Assets | -1.23 | -2.39 | 0.12 | -0.55 | -0.78 | -0.22 |
Operating Cash Flow | 3.03 | 2.07 | 0.94 | 1.23 | 4.09 | 3.05 |
Operating Cash Flow Growth | 134.94% | 118.98% | -23.46% | -69.88% | 34.13% | 127.78% |
Capital Expenditures | -0.19 | -0.19 | -0.55 | -0.12 | -0.49 | -0.3 |
Sale of Property, Plant & Equipment | 0.01 | - | - | 0 | 0.02 | - |
Investment in Securities | - | - | - | 0 | - | 0.1 |
Other Investing Activities | -0.01 | -0.01 | - | - | - | - |
Investing Cash Flow | -0.2 | -0.21 | -0.55 | -0.11 | -0.47 | -0.2 |
Short-Term Debt Issued | - | - | - | - | - | 57.66 |
Total Debt Issued | - | - | - | - | - | 57.66 |
Short-Term Debt Repaid | - | - | - | -0.1 | -2.07 | -59.54 |
Long-Term Debt Repaid | - | -0.01 | -0.04 | -0.04 | -1.47 | -1.19 |
Total Debt Repaid | -0.03 | -0.01 | -0.04 | -0.14 | -3.54 | -60.73 |
Net Debt Issued (Repaid) | -0.03 | -0.01 | -0.04 | -0.14 | -3.54 | -3.07 |
Issuance of Common Stock | 0.07 | 0.09 | 0.01 | - | 0.03 | 0.02 |
Financing Cash Flow | 0.03 | 0.08 | -0.03 | -0.14 | -3.51 | -3.04 |
Net Cash Flow | 2.87 | 1.94 | 0.36 | 0.99 | 0.12 | -0.19 |
Free Cash Flow | 2.84 | 1.87 | 0.39 | 1.12 | 3.61 | 2.76 |
Free Cash Flow Growth | 201.70% | 380.51% | -65.05% | -69.04% | 30.85% | 144.89% |
Free Cash Flow Margin | 5.88% | 3.45% | 0.78% | 2.20% | 6.41% | 4.33% |
Free Cash Flow Per Share | 0.09 | 0.06 | 0.01 | 0.04 | 0.11 | 0.09 |
Cash Interest Paid | 0.05 | 0.05 | 0.04 | 0.04 | 0.11 | 0.2 |
Cash Income Tax Paid | 0.08 | 0.08 | 0.04 | - | 0.47 | 0.56 |
Levered Free Cash Flow | 4.17 | 1.94 | 1.18 | 1.93 | 3.3 | 1.79 |
Unlevered Free Cash Flow | 4.2 | 1.97 | 1.21 | 1.94 | 3.38 | 1.95 |
Change in Working Capital | 2.59 | -1.5 | -0.74 | -0.3 | 0.51 | -3.05 |